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Benefits, risks and best practice in regional
anaesthesia
Relief from pain is a worthwhile humanitarian and clinical goal and
there is good evidence that regional anaesthesia and analgesia offer a supe-
rior quality of analgesia compared to opioid-based analgesia (1, 2, 3). For
this reason alone it may be argued that a regional technique should be of-
fered whenever clinically justified (4), although others may dispute this.
Unfortunately, it is more difficult to find good data to support the hypothe-
sis that regional anaesthesia can influence a reduction in surgical morbidity
and mortality, length of hospital stay, and other markers of improved out-
come from surgery.
In recent years, there has been a marked growth in the use of both
neuraxial and peripheral nerve regional anaesthesia techniques and con-
cerns have been raised about the potentially serious adverse events associated
with this increased use. We need to examine the currently available evidence
for both the risks and benefits associated with major regional techniques to
strike a balance, which can inform our clinical practice. Equally impor-
tantly, where such evidence is lacking, we can then identify the direction
that future research might take.
THE BENEFITS
There is a large database of published studies claiming to show ben-efits in favour of regional techniques compared to other anaes-
thetic and analgesic techniques. The problem is that when this data-
base is interrogated, the limitations of many of the studies become appar-
ent (underpowered, failure to control patient inclusion criteria, other in-
fluences on outcome, variable end point criteria etc.) making it difficult
to compare different studies. In 2000 the landmark CORTRA study (5),
demonstrated a significant reduction in mortality in the central neuraxial
group compared to the GA group. Criticisms of the methodology and
statistical analysis were soon raised, in particular, that the older studies
included did not represent current clinical practice. The MASTER trial
(6) contradicted the CORTRA study, finding that epidural infusions of-
fered no benefits other than good analgesia and some respiratory pro-
tection. In turn, this trial was also subject to detailed criticism. The un-
certainty generated by this lack of consistent data is partly to blame for a
decline in the use of epidural infusions for postoperative analgesia and
as the tendency of patients and lawyers to seek compensation grows,
many anaesthetists have become reluctant to continue to offer epidural
analgesia, even to those patients who might well benefit from them. In
the UK, a case series showing a raised incidence of epidural complica-
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lack of data about the incidence of both usage and com-
plications. The same is reported from other countries
(Canada, USA, Australia). The available randomised
studies do not have large enough patient numbers to
demonstrate a clear difference in mortality and morbid-
ity (8) and there are too many confounding variables.
The review by Liu (1) confirms that although regional
analgesia is superior to systemic opioid analgesia, im-
provement in specific outcome parameters (cardiovascu-
lar and respiratory) is restricted to particular patient sub-
sets and overall, there is no convincing evidence of im-
provement in outcome. A more recent review of neuraxial
analgesia confirms the same message; beyond the demon-
strable benefits of analgesia other perioperative benefits
are difficult to demonstrate, although there are small
positive effects that may prove to be clinically relevant. A
reduction in the incidence of chronic pain, better func-
tional recovery in the early postoperative period and,
possibly, a reduction in the recurrence rates for some
types of cancer are suggested in some studies but ade-
quately powered prospective studies are required to con-
firm or refute these findings (9).
THE RISKS
There is a similar large but confused database con-
cerning the risks of regional anaesthesia because some
studies do not distinguish between temporary and per-
manent harm. Serious permanent nerve damage associ-
ated with regional anaesthesia is rare; the mean incidence
of permanent damage is approximately 1:10,000, although
the range varies between different studies. Moen (10) of-
fers some useful retrospective data from the Swedish study
of neurological complications as it distinguishes between
spinals (1:20-30,000), obstetric (1:25,000) and non-obstet-
ric epidurals (1:3,600). Published rates of severe adverse
events associated with epidurals for major surgery range
from 1:875 (7) to 1:19,000 (11). A systematic review in
2007 calculated the incidence of both temporary and per-
manent injury for epidural, spinal and peripheral blocks
with differences noted between peripheral, spinal and
epidural techniques (12). The figures for neuraxial blocks
are in broad agreement with the NAP3 study (13).
The NAP3 project was a prospective study of risks in 5
pre-defined patient groups (paediatric, obstetric, periope-
rative, chronic pain and non- anaesthetic). It gathered a
snapshot census of data to provide an accurate figure as
the numerator and then collected all the severe complica-
tions notified nationally during the 12 month data collec-
tion period. With a total of 707,425 central blocks as the
numerator, the number of cases of spinal cord infarct, ver-
tebral canal haematoma, vertebral canal abscess, meningitis
and spinal cord and nerve root neuropathy included in the
analysis was 52, of which 22 made a full recovery during the
monitoring period. Perioperative epidurals produced more
than half of all the complications, with an incidence of be-
tween 1:5,700 (pessimistic) and 1:12,200 (optimistic).
NAP3 confirmed that different subsets of patients are
subject to differing risk, which means that we can now
offer patients a validated source of information regarding
risks associated with central neuraxial block in a variety
of clinical settings and separated into different categories
of complication.
BEST PRACTICE
Given the potential for rare but serious adverse events
associated with regional anaesthesia (14), we need good
data to define best practice, to demonstrate individual
competence and have safe and effective systems in place
to maximise benefits and minimise risks (15). Much of
our practice, until recently, has been custom and practice
– influenced by local and cultural factors, dependent on
the enthusiasm of individuals or groups of enthusiasts.
As RA has become part of „mainstream” anaesthetic care,
more concerted efforts to inform our practice with good
evidence have been developed (16, 17). The Australian
and New Zealand College of Anaesthetists 3rd edition of
the authoritative „Acute Pain Management: Scientific
Evidence” (18) which gives a balanced view about the
role of RA in acute pain management. Evidence is also
available to on a procedure-specific basis. The Prospect
working group (19) is an international collaboration of
anaesthetists and surgeons producing systematic reviews
and consensus clinical recommendations on a range of
surgical procedures, highlighting the role of RA, where
appropriate.
Both published literature (20, 21, 22) and web-based
material (19, 23) now provides systematic review evi-
dence to help construct clinical practice guidelines for a
number of surgical procedures. The data revealed by a
Prospect systematic review may also be robust enough to
generate further contributions to what is already known
about specific topics (24). With access to better informa-
tion about both the beneficial role of regional anaesthesia
in different procedures and the attendant risks, it is possi-
ble to establish standards of best practice, the aims of
which are threefold.
1. Optimal quality postoperative analgesia, with a mi-
nimum incidence of adverse events.
2. To enable the use of active rehabilitation program-
mes to accelerate recovery, improve mobility, optimise
functional recovery and reduce duration of hospital ad-
mission. This is the basis for the Enhanced Recovery Af-
ter Surgery „ERAS” programme
3. Improve long term outcome and potentially reduce
the incidence of chronic pain and poor functional results
due to the inadequate management of high-intensity
pain in the early postoperative period
Total hip arthroplasty serves as an example the com-
plexity in defining best practice. A meta-analysis compar-
ing central neuraxial techniques with general anaesthesia
confirmed that the regional techniques had significant
advantages over general anaesthesia with a reduced inci-
dence of thromboembolic events, blood loss, blood trans-
fusion and surgical operating time but there was no com-
parison of analgesic effectiveness (25). However, a second
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review (26) found only 18 randomised trials (1293 pa-
tients) that fulfilled their search criteria and the benefits of
regional anaesthesia were limited to improved pain
scores, less blood loss and fewer opioid related adverse
events. A third review (27), looking at both hip and knee
replacement, identified 21 papers, which showed a re-
duction in operating time, the need for transfusion, the
risk of DVT and PE. Methodological differences in these
reviews may explain their different findings and demon-
strate the difficulties in comparing even large reviews.
Other studies (28, 29) support the use of both spinal and
lumbar plexus block for hip arthroplasty. The current ev-
idence of best practice for hip replacement recommends
either a single-shot local anaesthetic spinal with a small
(100–200mcg) dose of morphine or a general anaes-
thetic with minimal opioid use combined with a lumbar
plexus block. Both techniques offer a good risk: benefit
profile. Local Infiltration Analgesia (LIA) is a new an-
algesic technique currently undergoing formal investi-
gation after initial clinical experience suggested that it
might have some benefit in lower limb joint replace-
ment (30-32). Currently, the limited RCT’s available
suggest that it is not useful for hip surgery although may
be useful for knee replacement.
Best practice is a complex concept and is subject to
significant influence by surgical as well as anaesthetic
factors. Ward routines and physiotherapy regimens, as
well as local medical custom and practice all influence
Best Practice; it is not simply „the Gold Standard” anaes-
thesia or analgesia technique. As surgical techniques
evolve and set new standards of recovery, rehabilitation
and mobilization in ERAS programmes, our analgesic
techniques also need to adapt and evolve to keep pace
(33–35).
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